BJU international

publication venue for

Deep haemangioma of the scrotum as a rare presentation of scrotal mass in children. 2003
Refining BCG-failure classifications in non-muscle-invasive bladder cancer. 2026
Impact of BCG failure patterns on efficacy of intravesical gemcitabine/docetaxel in high-risk non-muscle-invasive bladder cancer.. 137. 2026
Urologic chronic pelvic pain syndrome 3-year symptom trajectories: the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Symptom Patterns Study. 2025
Impact of microsurgical varicocelectomy on sperm capacitation and birth outcomes. 2025
External validation of an artificial intelligence model for Gleason grading of prostate cancer on prostatectomy specimens. 2024
Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified study.. 133. 2023
Findings from an international survey of urology trainee experience with prostate biopsy.. 131. 2022
Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy.. 129. 2021
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration.. 128. 2021
Longitudinal follow-up and performance validation of an mRNA-based urine test (Xpert^® Bladder Cancer Monitor ) for surveillance in patients with non-muscle-invasive bladder cancer.. 128. 2021
A risk calculator predicting recurrence in lymph node metastatic penile cancer.. 126. 2020
A comparative propensity score-matched analysis of perioperative outcomes of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.. 126. 2020
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma.. 125. 2020
Extraperitoneal single-port robot-assisted radical prostatectomy: initial experience and description of technique.. 125. 2019
Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration.. 124. 2019
A longitudinal analysis of urological chronic pelvic pain syndrome flares in the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.. 124. 2019
Step-by-step technique for single-port robot-assisted radical cystectomy and pelvic lymph nodes dissection using the da Vinci^® SP™ surgical system.. 124. 2019
Robot-assisted surgery for benign distal ureteral strictures: step-by-step technique using the SP^® surgical system.. 123. 2019
The duration of infertility affects semen parameters in primary infertile men: results of a single-centre, cross-sectional study.. 123. 2018
Achieving tumour control when suspecting sinus fat involvement during robot-assisted partial nephrectomy: step-by-step.. 123. 2018
Undiagnosed prediabetes is highly prevalent in primary infertile men - results from a cross-sectional study.. 123. 2018
Robot-assisted transvesical partial prostatectomy using a purpose-built single-port robotic system.. 122. 2018
Risk of hospitalisation after primary treatment for prostate cancer.. 120. 2016
Prostate size, nocturia and the digital rectal examination: a cohort study of 30 500 men.. 119. 2016
Robot-assisted partial cystectomy: perioperative outcomes and early oncological efficacy.. 119. 2016
Magnetic resonance microscopy may enable distinction between normal histomorphological features and prostate cancer in the resected prostate gland.. 119. 2016
Performance of robotic simulated skills tasks is positively associated with clinical robotic surgical performance.. 118. 2016
The safety of robot-assisted cystectomy in patients with previous history of pelvic irradiation.. 118. 2016
Risk of prostate cancer-specific death in men with baseline metabolic aberrations treated with androgen deprivation therapy for biochemical recurrence.. 118. 2016
A survey of patient expectations regarding sexual function following radical prostatectomy.. 118. 2016
Multiphoton microscopy for rapid histopathological evaluation of kidney tumours.. 118. 2015
Variation in serum prostate-specific antigen levels in men with prostate cancer managed with active surveillance.. 118. 2015
Gleason score 5 + 3 = 8 prostate cancer: much more like Gleason score 9?. 118. 2015
Association between number of prostate biopsies and patient-reported functional outcomes after radical prostatectomy: implications for active surveillance protocols.. 117. 2015
Impact of stage migration and practice changes on high-risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades.. 117. 2015
Real-time in vivo periprostatic nerve tracking using multiphoton microscopy in a rat survival surgery model: a promising pre-clinical study for enhanced nerve-sparing surgery.. 116. 2015
Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer.. 116. 2015
Preoperative predictive model of recovery of urinary continence after radical prostatectomy.. 116. 2015
Cigarette smoking during external beam radiation therapy for prostate cancer is associated with an increased risk of prostate cancer-specific mortality and treatment-related toxicity.. 116. 2015
Extended pelvic lymph node dissection in patients with prostate cancer previously treated with surgery for lower urinary tract symptoms.. 116. 2015
The effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density.. 115. 2015
Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer.. 116. 2014
Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3 + 4 prostate cancer.. 115. 2014
Subtyping of renal cortical neoplasms in fine needle aspiration biopsies using a decision tree based on genomic alterations detected by fluorescence in situ hybridization.. 114. 2014
Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysis.. 114. 2014
Erectile dysfunction in men treated for testicular cancer.. 113. 2014
Efficacy of robot-assisted radical cystectomy (RARC) in advanced bladder cancer: results from the International Radical Cystectomy Consortium (IRCC).. 114. 2014
Population-based determinants of radical prostatectomy operative time.. 113. 2014
MRI-safe robot for targeted transrectal prostate biopsy: animal experiments.. 113. 2013
Prospective analysis of penile length changes after radical prostatectomy.. 113. 2013
Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation.. 113. 2013
Sildenafil citrate improves erectile function after castration in a rat model.. 113. 2013
Phase II study of everolimus in metastatic urothelial cancer.. 112. 2013
Patterns of care and outcomes of radiotherapy for lymph node positivity after radical prostatectomy.. 111. 2013
Neutrophil gelatinase-associated lipocalin (NGAL) levels in response to unilateral renal ischaemia in a novel pilot two-kidney porcine model.. 112. 2013
Seminal vesicle involvement at salvage radical prostatectomy.. 111. 2013
Accuracy of post-radiotherapy biopsy before salvage radical prostatectomy.. 112. 2013
Can transrectal needle biopsy be optimised to detect nearly all prostate cancer with a volume of ≥0.5 mL? A three-dimensional analysis.. 112. 2013
Comparison of laparoendoscopic single site (LESS) and conventional laparoscopic donor nephrectomy at a single institution.. 112. 2013
Comparative assessment of three standardized robotic surgery training methods.. 112. 2013
Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007.. 112. 2013
Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?. 112. 2013
Impact of surgeon and volume on extended lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium (IRCC).. 111. 2013
A case-mix-adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons.. 111. 2013
Uncertainty and perception of danger among patients undergoing treatment for prostate cancer.. 111. 2012
Defining the impact of vascular risk factors on erectile function recovery after radical prostatectomy.. 111. 2012
The trifecta: great concept, lousy statistic.. 110. 2012
Systematic classification and prediction of complications after nephrectomy in patients with metastatic renal cell carcinoma (RCC).. 110. 2012
Clomiphene citrate is safe and effective for long-term management of hypogonadism.. 110. 2012
Impact of age on clinicopathological outcomes and recurrence-free survival after the surgical management of nonseminomatous germ cell tumour.. 110. 2012
Comparative effectiveness of cryotherapy vs brachytherapy for localised prostate cancer.. 110. 2011
Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.. 110. 2011
Evidence of bladder oversensitivity in the absence of an infection in premenopausal women with a history of recurrent urinary tract infections.. 110. 2011
Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer.. 110. 2011
Locally advanced prostate cancer: a population-based study of treatment patterns.. 109. 2011
Nodal counts during pelvic lymph node dissection for prostate cancer: an objective indicator of quality under the influence of very subjective factors.. 109. 2011
Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer.. 109. 2011
Anatomical grades of nerve sparing: a risk-stratified approach to neural-hammock sparing during robot-assisted radical prostatectomy (RARP).. 108. 2011
The dorsal venous complex (DVC): dorsal venous or dorsal vasculature complex? Santorini's plexus revisited.. 108. 2011
Measuring erectile function after radical prostatectomy: comparing a single question with the International Index of Erectile Function.. 109. 2011
Postoperative systems models more accurately predict risk of significant disease progression than standard risk groups and a 10-year postoperative nomogram: potential impact on the receipt of adjuvant therapy after surgery.. 109. 2011
Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer.. 109. 2011
Defining predictors of response to intralesional verapamil injection therapy for Peyronie's disease.. 108. 2011
Fifteen-year trend in the use of male reproductive surgery: analysis of the healthcare cost and utilization project data.. 107. 2011
Do pelvic dimensions and prostate location contribute to the risk of experiencing complications after radical prostatectomy?. 108. 2011
Multiphoton microscopy for structure identification in human prostate and periprostatic tissue: implications in prostate cancer surgery.. 108. 2011
Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy.. 108. 2011
Extending the indications and anatomical limits of pelvic lymph node dissection for prostate cancer: improved staging or increased morbidity?. 108. 2010
Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity.. 108. 2010
A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma.. 108. 2010
Trends in the care of radical prostatectomy in the United States from 2003 to 2006.. 108. 2010
Anatomical retro-apical technique of synchronous (posterior and anterior) urethral transection: a novel approach for ameliorating apical margin positivity during robotic radical prostatectomy.. 106. 2010
Are histopathological features of prostate cancer lesions associated with identification of extracapsular extension on magnetic resonance imaging?. 106. 2010
Bladder cancer in cystoscopically normal-appearing mucosa: a case of mistaken identity?. 106. 2010
Location and number of positive surgical margins as prognostic factors of biochemical recurrence after salvage radiation therapy after radical prostatectomy.. 106. 2010
Partial nephrectomy for selected renal cortical tumours of ≥ 7 cm.. 106. 2010
Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancer.. 107. 2010
Population-based determinants of radical prostatectomy surgical margin positivity.. 107. 2010
Early oncological outcomes for bladder urothelial carcinoma patients treated with robotic-assisted radical cystectomy.. 107. 2010
Radical nephrectomy with vena caval thrombectomy: a contemporary experience.. 107. 2010
Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy.. 107. 2010
The depth of the prostatic apex is an independent predictor of positive apical margins at radical prostatectomy.. 106. 2010
Novel ZEB1 expression in bladder tumorigenesis.. 107. 2010
Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implications.. 107. 2010
Urinary fistulae after partial nephrectomy.. 106. 2010
Visual cues as a surrogate for tactile feedback during robotic-assisted laparoscopic prostatectomy: posterolateral margin rates in 1340 consecutive patients.. 106. 2010
Lymph node dissection during robotic-assisted laparoscopic prostatectomy: comparison of lymph node yield and clinical outcomes when including common iliac nodes with standard template dissection.. 106. 2010
Extraprostatic extension of prostatic adenocarcinoma on needle core biopsy: report of 72 cases with clinical follow-up.. 106. 2009
Developments in the surgical management of sporadic synchronous bilateral renal tumours.. 105. 2009
Critical analysis of complications after robotic-assisted radical cystectomy with identification of preoperative and operative risk factors.. 105. 2009
The continuing role of prostate-specific antigen as a marker for localized prostate cancer: 'do not throw the baby out with the bath water'.. 104. 2009
Biochemical recurrence rate in patients with positive surgical margins at radical prostatectomy with further negative resected tissue.. 104. 2009
Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease.. 105. 2009
Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial.. 105. 2009
Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies.. 105. 2009
Drug treatment of urological symptoms: estimating the magnitude of unmet need in a community-based sample.. 104. 2009
Incidental angiomyolipoma resected during renal surgery for an enhancing renal mass.. 104. 2009
High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.. 104. 2009
Impact of ethnicity on surgical margins at radical prostatectomy.. 104. 2009
Recovery of erectile function after radical prostatectomy is quantitatively related to the response to intraoperative cavernous nerve stimulation.. 104. 2009
Outcomes after radical prostatectomy in men receiving previous pelvic radiation for non-prostate malignancies.. 104. 2009
p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer.. 104. 2009
Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy.. 104. 2009
Metanephric adenoma of the kidney: clinical and radiological study of nine cases.. 103. 2009
P-cadherin as a prognostic indicator and a modulator of migratory behaviour in bladder carcinoma cells.. 102. 2008
Advanced-stage renal cell carcinoma treated by radical nephrectomy and adjacent organ or structure resection.. 103. 2008
Comparison of gelatine matrix-thrombin sealants used during laparoscopic partial nephrectomy.. 102. 2008
Subclinical haemostatic activation and current surgeon volume predict bleeding with open radical retropubic prostatectomy.. 102. 2008
Nitrofurantoin: the return of an old friend in the wake of growing resistance.. 102. 2008
Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine.. 102. 2008
Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram.. 101. 2008
Modified technique for neurovascular bundle preservation during radical prostatectomy: association between technique and recovery of erectile function.. 101. 2008
Cancer control and the preservation of neurovascular tissue: how to meet competing goals during robotic radical prostatectomy.. 101. 2008
Adeno-associated viral vector transduction of green fluorescent protein in kidney: effect of unilateral ureteric obstruction.. 101. 2008
Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma.. 101. 2008
Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading.. 100. 2007
A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: results of the Cancer and Leukaemia Group B 90102.. 101. 2007
Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner.. 101. 2007
Prognostic significance of altered p120 ctn expression in bladder cancer.. 101. 2007
Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy.. 101. 2007
Prognostic significance of p27Kip1 expression in bladder cancer.. 100. 2007
Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.. 99. 2007
Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer.. 99. 2007
The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy.. 99. 2007
The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis.. 99. 2007
Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging.. 99. 2007
Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen.. 99. 2006
Impact of positive surgical margins in patients undergoing partial nephrectomy for renal cortical tumours.. 99. 2006
Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder.. 99. 2006
The clinical features of anterior prostate cancers.. 98. 2006
African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.. 98. 2006
Trends in the operative management of renal tumors over a 14-year period.. 98. 2006
Radical prostatectomy in patients infected with human immunodeficiency virus.. 98. 2006
The proximal neurovascular plate and the tri-zonal neural architecture around the prostate gland: importance in the athermal robotic technique of nerve-sparing prostatectomy.. 98. 2006
The impact of tumour location on the histological subtype of renal cortical tumours.. 98. 2006
Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4-7 cm.. 97. 2006
Physiological fatigue of smooth muscle contractions in rat urinary bladder.. 97. 2006
Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival.. 97. 2006
Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer.. 98. 2006
Mini-flank supra-11th rib incision for open partial or radical nephrectomy.. 97. 2006
Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology.. 96. 2005
Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?. 96. 2005
Laparoscopic vs open partial nephrectomy in consecutive patients: the Cornell experience.. 96. 2005
Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy.. 95. 2005
Managing varicoceles in children: results with microsurgical varicocelectomy.. 95. 2005
Celestial bodies and urinary stones: Isaac Newton (1641-1727)--health and urological problems.. 95. 2005
Partial nephrectomy for patients with a solitary kidney: the Memorial Sloan-Kettering experience.. 94. 2004
Perspectives on the natural history of recurrent prostate cancer after radical prostatectomy, based on the response to salvage radiotherapy.. 94. 2004
Structural changes in the bladder walls of pregnant and hormone-treated rats: correlation with bladder dynamics.. 94. 2004
Correlation of ultrasonographic and orchidometer measurements of testis volume in adults.. 93. 2004
The impact of sildenafil citrate on sexual satisfaction profiles in men with a penile prosthesis in situ.. 93. 2004
Laparoscopically assisted ureterocystoplasty.. 91. 2003
The role of thoracotomy in managing postchemotherapy residual thoracic masses in patients with nonseminomatous germ cell tumours.. 91. 2003
Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system?. 87. 2001
The concealed laparoscopic orchidopexy.. 86. 2000
Response to comments on 'Adverse in-hospital outcomes in patients with paraplegia who undergo radical prostatectomy'. 2026
Continued gender imbalance on panels at urology meetings. 2023
First-line vascular endothelial growth factor inhibitors for advanced renal cell carcinoma and the impact of new agents entering the treatment paradigm. 2017
Non-invasive diagnosis and monitoring of urothelial bladder cancer: are we there yet?. 124. 2019
Potential new strategies for the treatment of renal medullary carcinoma.. 120. 2017
Active surveillance for prostate cancer: is it too active?. 118. 2016
Optimal results come from optimal surgery and optimal (neoadjuvant) systemic therapy.. 113. 2014
Partial nephrectomy for renal cancer (part II): the impact of renal ischaemia, patient preparation, surgical approaches, management of complications and utilization. 2010
Partial nephrectomy for renal cancer: Part I. 2010
Retroperitoneal lymph node dissection after chemotherapy. 2009
Retroperitoneal lymph node dissection: reassessment of modified templates. 2009
A review of the pharmacokinetic and pharmacological properties of a once-yearly administered histrelin acetate implant in the treatment of prostate cancer. 2009
Clinical complete response as a surrogate for pathological response in bladder cancer: a systematic review and meta-analysis. 2026
Cannabis use and risk of testicular germ cell tumour: a systematic review and meta-analysis. 2025
Role of prostate artery embolization in the management of refractory haematuria of prostatic origin. 2016
Assessment of complication and functional outcome reporting in the minimally invasive prostatectomy literature from 2006 to the present. 2011
Current status of robotic partial nephrectomy (RPN). 2011
Review of current varicocelectomy techniques and their outcomes. 2011
Other biomarkers for detecting prostate cancer. 2009
Molecular events in germ cell tumours: linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin. 2009
Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer. 2008
Active and passive immunotherapy: vaccines and antibodies. 2007
Renal artery embolization: clinical indications and experience from over 100 cases. 2006
Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials. 2005
Correction of cystocele. 2005
Peyronie's disease: the epidemiology, aetiology and clinical evaluation of deformity. 2005
Neuroprotective strategies in radical prostatectomy. 2005
Novel agents for sexual dysfunction. 2003

VIVO Weill Cornell Medical College

BJU international Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)